Orexo accelerates its portfolio development
Dr. Nils-Otto Ahnfelt assumes position as Project Director
Orexo is further strengthening its organization through the recruitment of Dr. Nils-Otto Ahnfelt as Project Director, with the task of driving development of the company's product portfolio on a project basis. Dr. Ahnfelt will also be a member of Orexo's executive management team. Nils-Otto Ahnfelt has more than 20 years of industry experience, mainly from Pharmacia, and joins Orexo from Doxa AB, where he was head of the company's Research and Development .
Orexo uses existing and well-documented substances to rapidly develop new, innovative and patented pharmaceuticals. In 2004, the company's portfolio of development projects was further expanded and advanced. Dr. Nils-Otto Ahnfelt has been recruited as Project Director to further enhance Orexo's capacity and expertise in pharmaceutical development. He will also be a member of the Orexo Executive Management Team.
Orexo's product portfolio currently comprises a commercialized product, a number of product candidates at the clinical-development phase and some well-advanced formulation projects. The common denominator to all of Orexo's product development efforts is it's therapeutic need focus on products with considerable medical and commercial potential, which can be rapidly developed and patented at a lower risk and lower cost than conventional pharmaceutical drug discovery and development.
Other news from the department research and development
